Amygdala Pharmaceutical introduces VALPROXA ER-500 Tablets, containing Divalproex Sodium Extended Release 500 mg, designed for effective seizure control and mood stabilization. The formulation helps suppress seizure activity, supports stable neuronal firing, and enhances GABAergic transmission. VALPROXA ER-500 is indicated for epilepsy, bipolar disorder (mania), and migraine prevention, offering the convenience of a long-acting, once-daily regimen under medical supervision.
